by Julie Brill, Vermont Assistant Attorney General and Ano Lobb, M.P.H.
This report is the culmination of the National State Attorneys General Program's efforts to bring together State Attorneys General, academics, and state and federal regulators in an effort to focus on the role that State Attorneys General can play in curtailing current spending on pharmaceuticals by states, consumers, private insurers and employers. At a conference held at Columbia Law School in May 2007, with representation from 38 Attorney General offices, leaders discussed the policy options for states and Attorneys General to pursue in their efforts to implement savings of pharmaceutical dollars. The report summarizes the efforts of states and their Attorneys General in each of these areas, presenting specific solutions currently employed by various states for consideration.
